The Role of Somatic Mutation in the Generation of the Protective Humoral Immune Response against Vesicular Stomatitis Virus  by Kalinke, Ulrich et al.
Immunity, Vol. 5, 639–652, December, 1996, Copyright 1996 by Cell Press
The Role of Somatic Mutation in the Generation
of the Protective Humoral Immune Response
against Vesicular Stomatitis Virus
Ulrich Kalinke,* Etienne M. Bucher,* Bettina Ernst,* al., 1989). These germinal center B cells are the source
of memory B cells usually expressing a diverse reper-Annette Oxenius,* Hans-Peter Roost,* StephanGeley,†
toire of somatically mutated and affinity-selected anti-Reinhard Kofler,† Rolf M. Zinkernagel,*
bodies (Reth et al., 1978; Berek et al., 1985; Cumanoand Hans Hengartner*
and Rajewsky, 1986; Wysocki et al., 1986; Jacob and*Institute of Experimental Immunology
Kelsoe, 1992).8091 Zu¨rich
During most infections with cytopathic viruses, suchSwitzerland
as poliovirus, influenza virus, and rabies virus, neutraliz-† Institute of General and Experimental Pathology
ing antibody responses are generated early, i.e., within6020 Innsbruck
1 week (Ogra et al., 1980; Sabin, 1981; Webster andAustria
Rott, 1987; Klenk and Rott, 1988; Baer et al., 1990;
Zinkernagel, 1996). Such fast kinetics are necessary for
protection against lethal disease since neutralizing anti-Summary
bodies have to be present in the blood to prevent dis-
semination of virus to neuronal tissues. Once cytopathicDuring most clinically relevant infections with cyto-
viruses have entered neuronal tissues, antibodies arepathic viruses, neutralizing antibodies are generated
often no longer effective.early, i.e., within the first week of infection. As early
The extensive analysis of hemagglutinin (HA)-speci-as 4 days after immunization of mice with vesicular
fic antibodies generated from the immune responsestomatitis virus (VSV), a cytopathic virus closely re-
against influenza virus revealed the existence of a largelated to rabies virus, hybridomas could be isolated
degree of structural diversity among antibodies thatthat secreted virus-neutralizing IgGs. Such antibodies
share specificity for one antigenic site of HA (Staudt andwere devoid of somatic mutations, showed high bind-
Gerhard, 1983; Clarke et al., 1985; Caton et al., 1991).ing avidities (z109 M21), and used V gene fragments
Most HA-specific antibodies analyzed were somaticallypredominantly belonging to the VHQ52 and VK19-28 mutated, but some, isolated from the early primary re-families. In contrast, most secondary and hyperim-
sponse, displayed germline configuration (Clarke et al.,mune response IgGs isolated 12 and 150 days after
1990a; Kavaler et al., 1990). As with hapten-specific anti-infection used several additional V gene combinations.
bodies, the analysis of genealogically related HA-spe-These, which used the VHQ52/VK19-28 combination of cific antibodies indicated that binding avidities couldearly IgGs, were point mutated but showed only mar-
have been improved up to 30-fold by somatic mutation
ginally enhanced binding avidities. Since all VHQ52/ (Clarke et al., 1990b).
VK19-28-positive IgGs bound to one subsite within the The question therefore arose whether fast and effi-major antigenic site of VSV-G irrespective of the pres-
cient somatic hypermutation and affinity selection wasence or absence of somatic point mutations, fine spec-
involved in the generation of early virus-neutralizing anti-
ificity diversification of secondary and hyperimmune
bodies or whether antibodies in germline configuration
responses was achieved by newly appearing V gene
already were protective. To address this question, we
combinations.
analyzed the immunoglobulin response against vesicu-
lar stomatitis virus (VSV), a cytopathic virus closely re-
Introduction lated to rabies virus (Wagner, 1987). After VSV infection,
protection against progressive paralytic disease is cru-
The detailed analysis of the hapten-specific antibody cially mediated by virus-neutralizing antibodies (Lefran-
response against (4-hydroxy-3-nitrophenyl)acetyl (NP), cois, 1984; Bachmann et al., 1994). Histological in situ
2-phenyl-5-oxazolone (phOx), azophenylarsonate (Ars), studies revealed, that during the first 5 days after infec-
phosphorylcholine (PC), and other haptens has made tion, VSV-specific B cells were predominantly found in
an important contribution to the understanding of the the red pulp and in the marginal zone of the spleen. By
physiology of the early phase of the B cell response: day 6 after infection, germinal centers became detect-
after antigen-specific stimulation, B cells enter either able, and they were fully established by day 12 (Bach-
primary antibody–secreting or memory B cell pathways mann et al., 1996). The analysis of monoclonal antibod-
(Linton et al., 1989; Lalor et al., 1992). Primary antibody– ies (MAbs) revealed that all VSV-specific MAbs were
forming cells producing low affinity antibodies appear able to neutralize the virus and that the vast majority of
by day 2 after immunization in extrafollicular foci (Jacob VSV-specific MAbs cross-competed and therefore were
et al., 1991a) and express V regions which, depending directed against overlapping subsites clustered within
on the antigen, preferentially use particular V gene frag- one major antigenic site of the viral glycoprotein (VSV-G)
ments in germline configuration (Ma¨kela¨ and Karja- (Roost et al., 1995, 1996).
lainen, 1977; Gearhart et al., 1981; Kaartinen et al., 1983; The major antigenic site of VSV-G probably consists
Wysocki et al., 1986; Jacob and Kelsoe, 1992). Extrafol- of loops formed by disulfide bonds (Grigera et al., 1992)
licular foci expand until day 8 and then disappear on and represents the only protein region of VSV-G that is
following days (Smith et al., 1996). On days 8–10 of the accessible to B cells and antibodies on the surface of
primary response, germinal center B cells appear that intact virus. Neutralization-resistant virus variants se-
lected in the presence of distinct VSV-neutralizing MAbssecrete only small amounts of immunoglobulin (Liu et
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have been used to define antigenic subsites within the Table 1. Binding Avidity and Neutralizing Activity of VHQ52/VK19-
28-Positive VSV-Specific IgGs Secreted by Hybridomasmajor antigenic site of VSV-G (Lefrancois and Lyles,
Isolated 4, 12, and 150 Days after Infection1983; Vandepol et al., 1986; Luo et al., 1988). Owing to
the discontinuous nature of these subsites, particular Binding Aviditya Neutralizing Activityb
virus variants may have lost determinants for MAbs Clone (3108 M21) (titer·mg21·l21)
cross-competing either for the same or for different sub- Day 4
sites. Therefore in this study the cross-competition anal- 41.1 11 6.1
ysis was taken as a basis for defining the one major 41.2 11 8.0
41.3 3 5.1antigenic site, which may be calculated to represent
41.4 10 5.4about 1000 A˚2. A selected escape mutant virus was then
41.7 2 4.0used to define one particular subsite within the major
41.8 6 6.4
antigenic site. Thus, the major antigenic site is biologi- 41.9 15 4.0
cally well defined, although data on the three-dimen- 41.10 11 2.7
sional structure of VSV-G are so far not available. 41.11 7 3.0
41.15 5 5.8The comparison of VSV-specific MAbs isolated 6, 12,
41.17 17 7.5and 150 days after infection did not reveal evidence
Day 12for dose- and time-dependent overall improvement of
VI28 32 1300
avidity (Roost et al., 1995). This is in contrast with hap- VI32 16 960
ten-specific antibodies, which may increase affinity dur- VI10 30 437
ing the secondary and hyperimmune response by up to VI23 63 470
VI11 26 4022 orders of magnitude (Griffiths et al., 1984). In this study,
VI38 6 90we therefore analyzed the molecularstructure of primary
Day 150response VSV-neutralizing immunoglobulin Gs (IgGs).
VI49 59 2360
Monoclonal VSV-specific IgGs were isolated as early
BALB/c mice were immunized with VSV-IND intravenously, and afteras 4 and 5 days after infection, when germinal center
the indicated days spleen cells were fused to the myeloma cell lineformation and somatic mutation were not yet observed.
P3X63Ag8.653. Detailed protocols are described in Tables 2 and 3.The binding avidities of primary response IgGs and a Equilibrium association constant, Ka.
structurally related somatically mutated secondary and b Neutralizing activity is expressed as standardized neutralizing titer
hyperimmune response IgGs were compared. The data of monoclonal antibodies with a starting concentration of 1mg/ml.
presented indicate that somatic mutation and affinity
selection are not required for the generation of protec-
tive VSV-neutralizing antibodies. Although avidity does
binding avidity that was increased only 4-fold (Table 1).not improve with time, somatic mutations occur and the
However, comparison of the neutralization activity ofantibody repertoire shifts substantially.
structurally related primary response and secondary/
hyperimmune response IgGs revealed a 100-fold differ-Results
ence (Table 1).
VSV-Specific Monoclonal IgG Antibodies Isolated
The V Regions of VSV-Specific Primary Response4 and 5 Days after Infection Bind with High
IgGs Are Predominantly Encoded by V GeneAffinity and Neutralize VSV
Fragments Belonging to the VHQ52Previous experiments have shown that MAbs isolated
and VK19-28 Familiesas early as 6 days after VSV serotype Indiana (VSV-IND)
To analyze the structural basis of the primary VSV-neu-infection had high binding avidity and neutralized the
tralizing immunoglobulin response, the variable regionsvirus (Roost et al., 1995). Since germinal center forma-
of the immunoglobulin heavy and light chains (VH andtion had started by day 6 after VSV infection (Bachmann
VL, comprising the rearranged VH(D)JH and VKJK or VlJlet al., 1996), it was theoretically possible that these anti-
gene segments) of 23 IgG-secreting hybridomas, werebodies had been generated by very fast and efficient
cloned by reverse transcriptase–polymerase chain reac-somatic hypermutation and affinity selection. To test
tion (RT–PCR) and sequenced. Of the 23 hybridomaswhether VSV-neutralizing antibodies are present and ef-
analyzed, 15 were isolated from fusions of day 4 spleenfective in germline configuration, we screened for
cells, 14 of which derived from one single mouse, andIgG-secreting hybridomas 4 and 5 days after VSV-IND
8 hybridomas were obtained from fusions of spleen cellsinfection, when germinal center formation was not yet
taken from another mouse 5 days after infection (Table 2).observed (Bachmann et al., 1996) and thus somatic hyp-
Surprisingly, the V regions of 20 out of 23 hybridomasermutation was not yet expected to have occurred (Be-
analyzed could be PCR amplified with VHQ52 and VK19-rek et al., 1991; Jacob et al., 1991b; MacLennan, 1994).
28 family–specific primer combinations; 2 out of 23 hy-VSV-specific IgG antibodies isolated 4 days after in-
bridomas were positive with a VH7183 family–specifictravenous infection with 106 pfu of VSV-IND showed high
primer combination; and one hybridoma used a VH genebinding avidities of approximately 109 M21 and neutral-
fragment belonging to the VHJ558 family (Table 2).ized VSV (Table 1). Structurally related VSV-specific sec-
Sequence analysis of the PCR products revealed thatondary response IgGs isolated on day 12 after one
all hybridomas isolated 4 and 5 days after infection werebooster infection on day 9 and hyperimmune response
devoid of somatic mutations. Out of the 20 VHQ52/VK19-IgGs isolated on day 150 after repeated booster infec-
tions every 3 weeks (see below) showed an average 28-positive clones, 16 used a combination of the VHOX2
Restricted V Gene Usage of Early VSV-Neutralizing IgGs
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and VKSer germline gene fragments (Table 2). The major- VHOX2 (clones 41.8, 51.18, and 51.12), closely related
VH germline gene fragments were found (VH41.8 andity of these 16 clones used either the JH4 or the JH3
element (8 of 16 and 7 of 16 clones, respectively; Table VHQ52.51) that encoded the same amino acid sequences
in the complementarity-determining regions (CDRs) 12). In 3 of the 4 VHQ52/VK19-28-positive clones not using
Immunity
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and 2, such as VHOX2 (Figure 1). In the remaining VHQ52/ showed the VHQ52/VK19-28 combination, and of 19 hy-
bridomas isolated 150 days after infection, 1 (VI49)VK19-28-positive clone not using VHOX2 (clone 41.14),
the VHPJ14 germline gene fragment was found, which showed this combination. Thus, these 7 clones shared
structural characteristics with the majority of early pri-in comparison with VHOX2 showed several amino acid
differences in both the framework regions (FRs) and the mary response IgGs.
CDRs. The VL regions of all VSV-specific VHQ52-positive
antibodies isolated 4 and 5 days after infection (20 of 23
VHQ52/VK19-28-Positive Antibodies Isolatedclones) consisted of the VKSer germline gene fragment
12 and 150 Days after VSV Infection Bear(VK18-29 family) predominantly joined to the JK5 and the
Somatic Point MutationsJK1 segments (10 of 21 and 8 of 21 clones, respectively;
To assess whether the 7 VHQ52/VK19-28-positive hybrid-Table 2). The two VH7183-positive clones isolated 4 and
omas isolated 12 and 150 days after infection used the5 days after infection (clones 41.6 and 51.3) used the
same germline gene fragments as the majorityof primaryVH germline gene fragments VH61-1P and VH7183.9 (Ta-
response IgGs, the VH and VL nucleotide sequencesble 2).
were determined. The VH sequences of the clones VI28,Thus, the analysis of the VH and VL genes of VSV-
VI32, VI10, VI23, VI49, VI11, and VI38 differed in at leastspecific IgGs isolated 4 and 5 days after VSV infection
one nucleotide position from the VHOX2 and thebefore germinal center formation revealed the following:
VHQ52.51 germline gene fragments (Figure 1). The VLfirst, all VH and VL regions analyzed were devoid of
sequences of the two secondary response hybridomassomatic mutations; second, in 19 of 23 clones analyzed,
VI10 and VI11 showed complete sequence identity withidentical amino acid sequences were found in CDR1
the VKSer germline gene fragment, whereas the VL se-and CDR2 of VH and VL; third, the primary VSV-specific
quences of VI28, VI32, VI23, VI49, and VI38 showed atimmunoglobulin response was polyclonal, since only
least one nucleotide difference in comparison with theone pair of sibling clones expressing identical VH and
VKSer germline gene fragment (Figure 2). Thus, the 6 outVL sequences was found (clones 51.9 and 51.20); fourth,
of 32 secondary response IgGs and the 1 out of 19the variable region length of VHQ52/VK19-28-positive
hyperimmune response IgGs hybridizing with the VHQ52MAbs was in the range of 112–117 amino acids for the
and the VK19-28 family–specific probes showed highVH and 106–108 amino acids for the VL regions (Table
sequence homology with primary response IgGs. How-2; Figures 1 and 2); and, fifth, no common VH-CDR3
ever, none of the variable regions of the clones showedmotif could be detected in VHQ52/VK19-28-positive anti-
complete sequence identity with known germline genebodies.
fragments.
To determine whether the nucleotide positions in the
V regions differing from the known germline gene frag-V Regions of Secondary and Hyperimmune
Response VSV-Specific Antibodies Use ments were derived by somatic mutation or were germ-
line encoded, we analyzed the VH recombination of theSeveral Different V Gene Combinations
To establish whether secondary and hyperimmune re- hybridomas by Southern blot hybridization. If identi-
cal VH and JH segments were used during V(D)J re-sponse IgGs also showed a restricted V gene usage,
we analyzed the V region diversity of 51 hybridomas arrangement, Southern blot analysis of EcoRI-digested
genomic DNA hybridized with the heavy chain intronisolated from secondary and hyperimmune responses
against VSV by Northern dot blot hybridization. For this enhancer probe (HE-probe) should reveal a restriction
fragment of identical length for different hybridomas.purpose, RNA extracts were prepared from 107 hybrid-
oma cells (White and Bancroft, 1982) and hybridized The hybridomas VI28, VI32, VI10, and VI23 isolated 12
days after infection and the hybridoma VI49 isolated 150with well-established probes specific for 11 VH families,
12 VK families, and all JH and JK segments (Kofler, 1988; days after infection used the JH4 element as judged by
the VH nucleotide sequence (Figure 1). In the SouthernDuchosal et al., 1989; Kofler et al., 1989).
The hybridization data indicated heterogeneous and blot hybridization analysis of these hybridomas with the
HE-probe, a restriction fragment at 4.3 kb showed uppolyclonal secondary and hyperimmune responses us-
ing several V and J gene combinations. Secondary re- (Figure 3), indicating that the same VH germline gene
fragment was used in these hybridomas. To prove thatsponse hybridomas isolated on day 12 after a booster
infection on day 9 used VH gene fragments predomi- the 4.3 kb fragment represented the productively re-
arranged VH region, we isolated this fragment fromnantly belonging to the VH7183 (34%, 11 of 32 clones),
the VHQ52 (25%, 8 of 32 clones), and the VHJ558 (22%, EcoRI-digested genomic DNA of the hybridoma VI10 by
genomic l Zap cloning (Stratagene). Sequencing of the7 of 32 clones) gene families. The majority of VL regions
were composed of VK gene fragments belonging to the genomically cloned VH gene of the hybridoma VI10 con-
firmed the data obtained by RT–PCR cloning. Thus, theVK19-28 (28%, 9 of 32 clones) and the VK21 (25%, 8 of
32 clones) families (Table 3). Southern blot data together with the sequence informa-
tion indicated that the clones VI28, VI32, VI10, VI23, andHyperimmune response hybridomas isolated on day
150 after repeated booster infections every 3 weeks VI49 used the VHOX2 germline gene fragment and that
the nucleotide differences found in the VH genes of theseused VH gene fragments predominantly belonging to the
VHJ558 (42%, 8 of 19 clones) and the VH7183 (37%, 7 of hybridomas derived from somatic mutation.
In contrast, clone VI11, which also used the JH4 ele-19 clones) families (Table 3).
Out of 32 hybridomas isolated 12 days after infection, ment, showed restriction fragments of 4.5 and 4.7 kb
(Figure 3). This finding indicated the usage of another6 hybridomas (VI38, VI23, VI32, VI10, VI28, and VI11)
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Figure 1. Comparison of Nucleotide and Deduced Amino Acid Sequences of VH Genes of VHQ52/VK19-28-Positive VSV-Neutralizing Antibodies
VH sequences of VHQ52/VK19-28-positive hybridomas isolated 4 (41.3 and 41.8), 5 (51.18), 12 (VI28, VI32, VI10, VI23, VI11, and VI38), and 150
days after infection (VI49) are shown. Identity of nucleotide sequences with the VHOX2 germline gene fragment and the indicated JH segments
is indicated by a dash. Differences are marked by the respective nucleotide, and a change of the deduced amino acid is shown in the single
letter code. Codons are numbered according to Kabat et al. (1991). The VH sequences of the hybridomas 51.12, VI11, and VI38 and the
VHQ52.51 germline gene fragment used by these three clones are shown in comparison with the VHOX2 germline gene fragment that was used
by the clones 41.3, VI28, VI32, VI10, VI23, and VI49. In comparison with the VHOX2 germline gene fragment, the VH genes of the hybridomas
41.8 and 51.18 showed three nucleotide exchanges at identical positions in FR3, of which one is silent and the other two encode an asparagine
to aspartic acid exchange at amino acid position 85 and an alanine to valine exchange at amino acid position 93, respectively. Since both
hybridomas were not related and were derived from independent mice, it was unlikely that the VH sequences of the clones 41.8 and 51.18
were derived by random mutation. Therefore most probably an as yet undescribed VH germline gene fragment (VHQ41.8) belonging to the
VHQ52 family was used in these hybridomas.
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Figure 2. Comparison of Nucleotide and Deduced Amino Acid Sequences of VL Genes of VHQ52/VK19-28-Positive VSV-Neutralizing Antibodies
The sequences of the VL genes of the same hybridomas as shown in Figure 1 are compared with the VKSer germline gene fragment and the
indicated JK segments (for notation and numbering see the legend of Figure 1).
germline gene fragment in addition to VHOX2. The clone Taken together, the VH regions of VHQ52/VK19-28-
VI38, which used the JH2 element, showed a restriction positive hybridomas isolated from secondary and hyper-
fragment of 5.5 kb, about 1 kb longer than the 4.5 kb immune responses used the VHOX2 and the VHQ52.51
fragment of VI11 (Figure 3). Since on the genomic level germline gene fragments that were also found in primary
JH2 and JH4 are separated by 1 kb, the different restric- response IgGs. In contrast with VHQ52/VK19-28-positive
tion fragment patterns of VI11 and VI38 were compatible hybridomas isolated from primary responses, all VHQ52/
with the usage of the same VH germline gene fragment VK19-28-positive hybridomas isolated from secondary
in both clones. Indeed, together with the VH sequence and hyperimmune responses showed somatic point mu-
information, the data indicated that the hybridomas VI11 tations, some of which were found repeatedly at the
and VI38 used the VHQ52.51 germline gene fragment same positions within the CDRs (amino acid position 35
(Figure 1). in clones VI32, VI10, VI23, and VI11 and amino acid
position 50 in clones VI28, VI32, VI49, and VI38) and in
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Table 3. Variable Region Diversity of VSV-IND-Neutralizing IgGs Generated 12 and 150 Days after VSV-IND Immunization
Day 12 Antibodies Day 150 Antibodies
Clone VH JH VK JK Clone VH JH VK JK
VI40 J558 1 10 2 or 4 VI46 J558 1 21 1
VI13 J558 1 npa 2 or 4 VI57 J558 2 5 5
VI17 J558 2 np 1 VI47 J558 2 12 2 or 4
VI39 J558 3 np 2 or 4 VI56 J558 2 np 2 or 4
VI19 J558 4 1 1 VI58 J558 2 np 5
VI31 J558 4 5 2 or 4 VI62 J558 3 5 1
VI27 J558 4 np 1 VI48 J558 4 19-28 5
VI60 J558 np 21 4
VI16 Q52 3 23 2 or 4
VI41 Q52 4 10 2
VI38 Q52 2 19-28 4 VI49 Q52 4 19-28 1
VI23 Q52 4 19-28 1
VI28 Q52 4 19-28 2
VI32 Q52 4 19-28 2
VI10 Q52 4 19-28 2
VI11 Q52 4 19-28 4
VI37 36-60 3 21 1 VI45 36-60 1 12 1
VI36 36-60 3 21 1
VI12 7183 1 19-28 1 VI54 7183 1 1 4
VI24 7183 2 8 2 VI55 7183 2 l l
VI20 7183 2 21 2 VI52 7183 2 8 5
VI30 7183 2 21 2 VI53 7183 2 9 1
VI26 7183 2 21 2 VI43 7183 2 12 2
VI22 7183 2 21 2 VI51 7183 2 np np
VI42 7183 3 21 1 VI44 7183 4 5 np
VI18 7183 3 23 1 VI50 7183 4 12 2 or 4
VI25 7183 3 19-28 4
VI15 7183 4 12 1
VI14 7183 4 19-28 1
VI34 3609 4 21 5 VI61 3609 4 21 4
VI7 10 1 np 2 or 4
VI33 10 4 5 4
VI29 10 4 9 or 10 1
The V gene usage of secondary response IgGs isolated on day 12 after one booster infection on day 9 and of hyperimmune response IgGs
isolated on day 150 after repeated booster infections every 3 weeks was determined by Northern dot blot hybridization with various V family
and J segment–specific probes. The monoclonal VSV-specific antibodies were generated after intravenous immunization of BALB/c mice with
2 3 103 or 2 3 106 pfu VSV-IND and fusion of spleen cells to X63Ag8.653 (Roost et al., 1995). Bold fonts indicate a group of antibodies sharing
structural features of antibodies dominating the early day 4 and 5 VSV-specific immune response (VHQ52/VK19-28-positive clones).
a np stands for ‘‘no probe positive’’ for those RNA extracts that did not hybridize with one of the probes used.
the FR3 (amino acid position 84 in clones VI32, VI10, VH and VL, two identical somatic point mutations in both
clones (one replacement mutation in VH and one silentand VI11; Figure 1).
At position50 the predominant mutation ledto a highly mutation in VL; Figures 1 and 2), and the identical length
of the 4.8 kb restriction fragment encoding the nonpro-conservative valine to leucine exchange. In this region
the germline nucleotide sequence is identical with ductively rearranged VH allele in both clones (Figure 3).
Since VI28 carried only one somatic amino acid changethe mutational hot spot sequence AGC/T, which has
been identified on a passenger transgene (Betz et al., in VH-CDR1 (Val-50 to leucine) and VI32 showed four
additional ones, two in VH (His-35 to tyrosine and Ala-1993). Interestingly, the valine to leucine exchange was
achieved by a G to C transversion at the second position 84 to valine) and two in VL (Ser-30 to asparagine and
Tyr-96 to cysteine), we assumed that VI28 was the pre-of the mutational hot spotsequence, a pattern which has
been shown to be one preferential intrinsic nucleotide cursor of VI32. Interestingly bothclones showed approx-
imately the same avidity (Table 1).substitution (Betz et al., 1993). In contrast, the mutations
at position 35 displayed no preference for particular
residues, which might indicate the absence of antigen-
driven selection. Therefore it was possible that the so- Fine Specificity of
VHQ52/VK19-28-Positive Hybridomasmatic amino acid changes in the CDRs were at least
partially due to the intrinsic specificity of the hypermuta- So far, the data indicated that within the group of VHQ52/
VK19-28-positive VSV-specific hybridomas, primary re-tion mechanism.
This was also suggested by the comparison of the sponse IgGs showed germline configuration, whereas
secondary and hyperimmune response IgGs using iden-two clones VI32 and VI28 (Figures1 and 2). These hybrid-
omas were genealogically related, as indicated by the tical germline gene fragments were somatically mu-
tated. We therefore tested whether the presence or ab-usage of identical V and J germline fragments, the nucle-
otide sequences found at the recombination joints of sence of somatic amino acid changes had any influence
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bound by other VSV-specific antibodies, we performed
binding competition experiments. For this purpose the
VSV-G surface expression on EL4 cells infected with
wild-type VSV-IND was analyzed cytofluorimetrically
(Roost et al., 1996). Infected cells were incubated with a
limiting amount of the VSV-IND-neutralizing rat antibody
IND5H6, and bound rat antibody was detected by a
phycoerythrin-labeled anti-rat IgG reagent (Figure 5A).
Previously bound mouse antibody reduced binding of
the rat antibody to background levels if the mouse and
the rat antibody competed for the same subsite (e.g.,
VI43; Figure 5B). In those cases where the mouse anti-
body bound a subsite different from that bound by the
rat antibody the surface staining was not affected (e.g.,
VI41; data not shown). All VHQ52/VK19-28-positive anti-
bodies reduced binding of the rat antibody IND5H6 by
factors between 2 (VI28; Figure 5C) and 5 (VI38; data not
shown). This pattern indicated that the subsite bound
by VHQ52/VK19-28-positive antibodies and the subsite
bound by the rat antibody IND5H6 were distinct, but
that they were overlapping. Thus, the majority of early
Figure 3. Southern Blot Analysis of VH Rearrangements of VSV- primary response IgGs were directed to one subsite
Neutralizing Hybridomas within the major antigenic site of VSV-G that was in
Genomic DNA isolated from the indicated hybridomas was digested close proximity to other subsites of the major antigenic
with EcoRI and hybridized with the heavy chain intron enhancer
site recognized by most of the secondary and the hyper-probe (HE-probe). The VHQ52/VK19-28-positive clones VI28, VI32,
immune response IgGs.VI10, VI23, VI49, and VI11 have undergone productive VH re-
arrangements to JH4. However, only the clones VI28, VI32, VI10,
VI23, and VI49 displayed a restriction fragment of 4.3 kb (arrowhead
on the left border), indicating the usage of one identical VH germline Discussion
gene fragment in these clones. The hybridoma VI11 used a different
member of the VHQ52 family. Although the clones VI11 and VI38 After infection with clinically relevant cytopathic viruses
showed divergent rearrangements, the band patterns are consistent
such as influenza virus, poliovirus, and rabies virus, neu-with the productive rearrangement of one identical VH gene fragment
tralizing antibodies appear early, i.e., within the firstin both clones. Hybridoma VI41, which is positive for the VHQ52/
week after infection (Ogra et al., 1980; Sabin, 1981; Web-VK10 family–specific probes (and thus is not assigned to the group
of VHQ52/VK19-28-positive hybridomas), has undergone productive ster and Rott, 1987; Klenk and Rott, 1988; Baer et al.,
rearrangement to the JH4 segment and shows a restriction fragment 1990; Zinkernagel, 1996). Despite the increasing knowl-
of 6 kb, indicating the usage of a third member of the VHQ52 family. edge about the physiology of hapten-specific B cell re-
The size of a molecular weight marker is indicated in kilobase pairs
sponses, the mechanism involved in the generation ofon the right border.
early virus-neutralizing antibodies is still a matter of de-
bate (Wabl and Steinberg, 1996). We thereforeexamined
the B cell response in mice infected with VSV, a cyto-on the fine specificity of VHQ52/VK19-28-positive anti-
bodies. For this purpose the different hybridoma super- pathic virus closely related to rabies virus (Wagner,
1987).natants were tested for neutralization of a VSV-IND
antibody escape variant and VSV-IND wild type. The Here we describe the isolation of high avidity virus-
neutralizing IgGs 4 and 5 days after intravenous infec-VSV-IND antibody escape variant was selected in the
presence of the primary response VHQ52/VK19-28-posi- tion of mice with VSV-IND. Nucleotide sequence analy-
sis of the variable regions of such antibodies revealedtive VSV-IND-neutralizing antibody 51.12. It was resis-
tant to neutralization by the MAb 51.12 as well as by all absence of somatic mutations. This finding was in
agreement with the observation that germinal centerother VHQ52/VK19-28-positive antibodies isolated 4, 5,
12, and 150 days after immunization, irrespective of the (GC) formation, which is required for somatic hypermu-
tation and affinity selection (Berek et al., 1991; Jacobpresence or absence of somatic mutations (Figure 4).
All VSV-IND-specific antibodies tested that did not use et al., 1991b), was not observed before 6 days after
VSV immunization (Bachmann et al., 1996). Antibodiesthe VHQ52/VK19-28 combination neutralized the VSV
variant 51.12 as efficiently as the wild-type virus. Thus, in germline configuration have previously been isolated
from several primary immune responses against hap-the VSV-IND variant 51.12 was lacking a determinant
that was critically recognized by structurally related tens (Ma¨kela¨ and Karjalainen, 1977; Gearhart et al., 1981;
Kaartinen et al., 1983; Wysocki et al., 1986) and patho-VHQ52/VK19-28-positive hybridomas. These results indi-
cated that the majority of early day 4 and 5 antibodies gens (Claflin and Berry, 1988; Clarke et al., 1990a; Ka-
valer et al., 1990). Interestingly, an early class switch tobound a subsite within the major antigenic site of VSV-G
that was distinct from subsites recognized by most sec- IgG has also been observed after primary influenza virus
infection in a B cell subset termed C12 (Kavaler et al.,ondary and hyperimmune response antibodies.
To measure the physical proximity of the subsites 1990). The same subset seemed to be highly susceptible
to negative selection in transgenic mice expressing thebound by VHQ52/VK19-28-positive IgGs and the subsites
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Figure 4. Neutralization of the VSV-IND Variant 51.12 and Wild-Type VSV-IND by Different Hybridoma Supernatants
Neutralization of the VSV-IND variant 51.12 (closed bars) and wild-type VSV-IND (open bars) by different VSV-specific MAbs isolated 4, 5, 12,
and 150 days after immunization is shown in standardized neutralizing titers. The VSV-IND variant 51.12 was selected in the presence of the
primary response IgG 51.12 isolated 5 days after infection.
target antigen HA as a neo–self-antigen (Caton et al., one can speculate on which form of T help is involved
in this process.1996). Thus, maximal cross-linking of surface IgG as it
happens after binding of VSV (and influenza virus and Primary response VSV-specific IgGs preferentially
used one VK germline gene fragment (VKSer) in combina-probably many other viruses exhibiting crystalline-like
multimeric identical antigenic sites) to antigen-specific tion with one of three closely related VH germline gene
fragments (VHOX2, VHQ52.51, or VH41.8) that all belongB cells apparently triggers B cells in a very efficient
manner, which is not seen with monomeric soluble anti- to the VHQ52 family and encode identical amino acid
sequences in the VH CDR1 and CDR2. Differencesgens (Bachmann et al., 1995). This efficient induction
and expansion of specific B cells yields high numbers among the amino acid sequences encoded by the three
VH germline gene fragments VHOX2, VHQ52.51, andof IgM-secreting B cellswhich can receive T help already
by day 4. Further investigations will be necessary before VH41.8 were found in FR3 at the amino acid positions
Figure 5. Analysis of Binding Competition
Flow cytometric analysis of VSV-G surface
staining of VSV-IND-infected EL4 cells with
rat MAb IND5H6 in the absence of competing
antibodies (A) and in the presence of compet-
ing mouse antibodies VI43 (B) and VI28 (C).
The mean fluorescence intensity (MFI) is indi-
cated.
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85 and 93. Despite sequence identity within the CDRs, day 12 after one booster immunization on day 9 showed
several somatic mutations. Some of these somatic mu-one of the three VH germline gene fragments (VHOX2)
was predominantly found in the day 4 and 5 MAbs. tations were repeatedly found at the same residue posi-
tions, e.g., in VH at amino acid positions 35, 50, and 84Previous studies have shown that FR residues may di-
rectly contact the antigen (Davies et al., 1990) or that (Figure 1). Since position 35 displayed no selection for
particular residues, and at positions 50 and 84 the germ-they may indirectly affect binding by influencing the anti-
body folding and assembly (Chen et al., 1994). However, line nucleotide sequence showed identity with the muta-
tional hot spot sequence AGC/T, and the predominantthree-dimensional modeling of the Fv portion of the anti-
bodies has suggested a peripheral localization of the mutation in position 50 matched a preferred intrinsic
mutational pattern identified in a passenger transgeneamino acid position 85 on the opposite side of the anti-
gen-binding site (A. Plu¨ckthun and A. Honegger, per- (Betz et al., 1993), it was possible that these somatic
amino acid changes were due to the intrinsic specificitysonal communication), making a direct antigen contact
of this residue very unlikely. Therefore, the skewed of the hypermutation mechanism instead of antigen-
driven selection. This was also suggested by compara-VHOX2 usage of early VSV-specific IgGs probably was
not achieved by antigen-driven selection. Surprisingly, ble binding avidities of two genealogically related hy-
bridomas (VI28 and VI32) that differed in four amino acidthe naive B cell repertoire of adult mice already shows
a skewed VHOX2 expression (Lawler et al., 1987). Thus, positions, two of which were positions 35 and 84.
However, mutational hot spots probably have beenafter antigen challenge there is an increased chance to
activate VHOX2-expressing B cells, which could explain selected during evolution and would be located at posi-
tions where amino acid substitutions could most effec-the skewed VHOX2 usage in early VSV-specific IgGs.
However, it remains unclear whether a gene position tively lead to an avidity increase. Therefore, it cannot
be excluded that some intrinsic mutations are able toeffect or selection by exposure to exogenous antigens
is the cause for a skewed VH expression in the naive increase binding avidities. If this were true for position
50, VI28 could have reached an affinity ceiling after therepertoire of adult mice (Bos and Meeuwsen, 1989).
Besides antibodies using the VHQ52/VK19-28 combi- Val-50 to leucinechange and avidity would not be further
increased by additional somatic mutations in VI32.nation, some primary VSV-specific antibodies displayed
different V gene combinations (clones 41.6, 51.2, and The occurrence of comparable avidities in clones dif-
fering in several amino acid positions contrasts with51.1). This finding illustrates that the predominant occur-
rence of the VHQ52/VK19-28 combination in VSV-specific genealogically related influenza virus–specific antibod-
ies, which may have increased the relative binding avid-primary response IgGs is not due to the incapability of
the animal to generate other antigen-specific structures, ity up to 30-fold by somatic hypermutation (Clarke et
al., 1990b).as was suggested to be the reason for the restricted
immunoglobulin responses against carbohydrate deter- Despite comparable binding avidities of structurally
related primary, secondary, and hyperimmune responseminants of Haemophilus influenzae (Adderson et al.,
1991) and Cryptococcus neoformans (Casadevall and VSV-specific IgG antibodies, the specific neutralizing
capacity of secondary and hyperimmune antibodieswasScharff, 1991). At this point the question arose why anti-
bodies using certain V gene combinations were under- about two orders of magnitude higher than that of pri-
mary response IgG antibodies. For VSV-specific anti-represented in the primary response against VSV.
VSV-specific primary response IgGs using the VHQ52/ bodies isolated 12 and 150 days after infection, it was
shown that their avidity and affinity were virtually theVK19-28 combination showed identical amino acid se-
quences in CDR1 and CDR2 of VH and VL, but did not same, indicating that bivalent binding had only a limited
contribution to the binding strength by multivalencyexhibit a common motif in CDR3. Furthermore, the early
VSV-specific immunoglobulin response in mice with a (Roost et al.,1995). It has been suggested that the avidity
of VSV-specific antibodies reaches a certain thresholdnull mutation in the terminal deoxynucleotidyl trans-
ferase (TdT) gene, which harbor lymphocytes express- that cannot be overcome (Foote and Eisen, 1995). In
contrast, the VSV-neutralizing antibody with the lowesting T and B cell receptors devoid of N-region diversity
in CDR3, was normal (Gilfillan et al., 1995). These obser- avidity in the collection of analyzed hybridomas (VI41;
Roost et al., 1995) revealed a great influence of bivalentvations indicated that no particular motif was required
at the recombination joints of VHQ52/VK19-28-positive binding on the binding strength. This was analyzed in
an enzyme-linked immunosorbent assay (ELISA) with aVSV-specific antibodies in order to retain specificity.
Such relaxed requirements may have favored the stimu- single-chain Fv reagent (scFv41) generated from the
parental antibody VI41 (U. K. and C. Bo¨se, unpublishedlation of VHQ52/VK19-28-positive B cells.
Comparable conclusions have been drawn for primary data): VSV-specific binding of monovalent scFv41 was
about 50-fold reduced in comparison with binding ofinfluenza virus–specific responses directed against the
HA (Caton et al., 1986; Clarke et al., 1990a; Kavaler et cross-linked scFv41. Therefore, affinity differences be-
tween primary and secondary/hyperimmune responseal., 1990, 1991). In one such example, influenza virus–
specific MAbs binding to one of the four antigenic sites IgGs might be larger than suggested by the avidity differ-
ences measured for these antibodies. Bivalent bindingof the HA termed Cb used the VHJ558/VK4-5 combina-
tion. Such antibodies also seemed to tolerate great vari- may have some influence on the neutralizing capacity
of virus-specific antibodies (Emini et al., 1983; Ubol etability in the junctional regions and still kept specificity
for the antigen (Kavaler et al., 1990). al., 1995). Since the influence of monovalent or bivalent
binding on the neutralizing capacity of different VSV-In accordance with the appearance of GCs by day 6
after VSV infection, VSV-specific antibodies isolated on specific antibodies cannot currently be evaluated, it is
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antibodies require certain motifs in CDR1, CDR2, and
CDR3 (Ma¨kela¨ and Karjalainen, 1977; Gearhart et al.,
1981; Wysocki et al., 1986). In one extreme example,
most phOx-specific day 7 primary response antibodies
used the VHOX1/VKOX1 combination and showed strong
restrictions in the D/J regions (Kaartinen et al., 1983).
However, in the secondary response, less than 20% of
the phOx-specific hybridomas secreted antibody mole-
cules that showed the VHOX1/VKOX1 combination pre-
dominantly found in the primary response (Griffiths et
al., 1984). The affinity increase of secondary response
hybridomas using VHOX1/VKOX1 did not necessarily cor-
relate with the increased number of somatic mutations.
The majority of phOx-specific secondary response IgGs
used VH gene fragments that were not found in primary
Figure 6. B Cell PopulationDynamics during theVSV-IND-Neutraliz- response hybridomas and mainly belonged to the
ing Immune Response
VH7183 and VHJ558 families (Berek et al., 1985).
The proportion of hybridomas using VH gene fragments belonging Similar population changes in secondary hapten-spe-
to the indicated VH families is shown for the VSV-specific immune cific immunoglobulin responses have also been re-response 4, 5, 12, and 150 days after VSV-IND infection.
ported for NP (Reth et al., 1978) and Ars (Wysocki et al.,
1986). In the case of the PC-specific response, primary
a matter of speculation whether the differences in the response antibodies predominantly express the T15 idi-
neutralizing capacity of primary versus secondary/hy- otope and bind the PC moiety of the coupled hapten
perimmune antibodies correlate with affinity differences (Chang et al., 1982). Secondary PC-specific IgGs with
of these antibodies. higher affinities than primary IgGs generally use new V
The V gene analysis of hybridomas obtained after combinations that do not display the T15 idiotope and
different immunization regimens revealed B cell popula- express a larger contact area for the antibody–hapten
tion dynamics during the immune response. Primary interaction involving the PC moiety and the azophenyl
response IgGs isolated 4 and 5 days after immunization spacer (Lo¨tscher et al., 1992). Interestingly, secondary
were virtually monomorphic, whereas secondary and PC-specific responses against Streptococcus pneu-
hyperimmune response IgGs isolated 12 and 150 days moniae do not show extensive population shifts (Claflin
after infection used several additional V gene combina- and Berry, 1988), and somatic mutation does not seem
tions. VHQ52/VK19-28-positive antibodies dominating to play a critical role: protection of mice against lethal
the primary response werereplaced after booster immu- S. pneumoniae infection was comparably efficient with
nizations by antibodies using VH gene fragments pre- T15-related antibodies in germline configuration as with
dominantly belonging to theVH7183 and the VHJ558 fami- mutated ones (Briles et al., 1984).
lies (Figure 6). It is possible that this shift is simply driven For the PC-specific MAbMcPC603, X-ray studies indi-
by disappearance of extrafollicular foci B cells (Smith et cate an antibody–hapten contact area of 161 A˚2 (Padlan
al., 1996), which predominantly secrete VHQ52-positive et al., 1985). Antibody–protein interactions analyzed so
antibodies in the case of a VSV-specific immune re- far involve larger contact areas of about 700 A˚2 (Davies
sponse. In parallel, population changes might be driven et al., 1990). This might be one reason why the initial
by deleteriously mutating VSV-specific antibodies that binding strength of VSV-neutralizing antibodies is ap-
exhibited high avidities already in the germline configu- proximately 109 M21,whereas most hapten-specific anti-
ration. The destruction of antigen specificity by random bodies display an initial affinity of 105 to 106 M21. The
changes of amino acids in the variable regions has been larger antibody–protein contact area might also explain
demonstrated for comparably low affinity primary and why VSV-specific VHQ52/VK19-28-positive MAbs do not
secondary hapten (PC)-specific antibodies (Chen et al., require a common motif in VH-CDR3 to retain specificity.
1992, 1995). It remains to be tested experimentally Furthermore, somatic amino acid changes in VSV-spe-
whether VH7183- and VHJ558-positive antibodies that cific antibodies might only improve details of the anti-
replaced VHQ52-positive antibodies in the secondary re- body–antigen contact area, and therefore the avidity
sponse were indeed improved by somatic hypermuta- differences between primary and secondary/hyperim-
tion and affinity selection in the GCs. mune IgGs are considerably less pronounced than affin-
Our data do not support the postulate that somatic ity differences found in hapten-specific antibodies.
mutation generates new specificities that could neutral- In conclusion, the VSV infection of mice provides a
ize antibody escape variants. All VHQ52/VK19-28-posi- model situation with which tostudy the antibody interac-
tive antibodies differing in the CDR3 motifs and in the tion with protein antigenic sites relevant for immune
degree of somatic mutation bound one subsite defined protection against lethal disease. This study shows the
by one particular VSV antibody escape mutant. Thus following: early primary response VSV-neutralizing IgGs
during somatic mutation the fine specificity of VSV-neu- are predominantly directed against one subsite within
tralizing antibodies was not detectably altered. the major antigenic site of VSV-G. Such antibodies use
In contrast with the primary immunoglobulin response one VK germline gene fragment and one of three different
against antigenic sites of the glycoproteins of VSV and VH germline gene fragments sharing identical CDR se-
quences. They are free of somatic mutations and do notinfluenza virus, most hapten-specific primary response
Immunity
650
Isolation of VH and VL Genes by RT–PCRrequire particular motifs in VH-CDR3 in order to retain
and Sequencing of PCR Productsspecificity. Most secondary and hyperimmune response
For the amplification of the V genes by Taq polymerase (BoehringerVSV-specific IgGs use several additional V gene combi-
Mannheim), poly(A)1 mRNA was isolated from 107 hybridoma cells
nations and recognize different subsites within the one using the Quick Prep Micro mRNA Purification Kit (Pharmacia), and
major antigenic site of VSV-G. The data indicate that the mRNA was reverse transcribed using AMV reverse transcriptase
(Amersham). For amplification of the VH genes, the primer (59-CAGsomatic mutation is not required for the generation of
GTGCAGCTGAAGCAGTCAGG-39) complementary to the nucleotideprotective virus-neutralizing antibodies. However, so-
sequence encoding the first 8 amino acids of the VHOX2 membermatic mutationsoccur, but do not alter theoverall avidity
of the VHQ52 family and the primer (59-CCGATGGGGCTGTTGTTand specificity of one particular antibody group. Anti-
TTG-39) complementary to sequences within the Cg1 domain were
body population changes were observed during the sec- used. For the amplification of the VL genes, the primer (59-CATAACC
ondary/hyperimmune response when maximal somatic TGCAAGGCCAG-39) complementary to the nucleotide sequence en-
coding the amino acids 20–26 of the VKSer germline gene fragmentmutation occurred. Therefore one might speculate that
and the primer (59-TGTCGTTCATACTCGTCCTTGGTCA-39) comple-too extensive somatic mutation “destroyed” high avidity
mentary to nucleotide sequence in the CK domain were used.clones in germline configuration, allowing new V gene
PCRproducts werepurified using the QIAquick Spin PCR Purifica-combinations to arise.
tion Kit (Qiagen) and were directly sequenced using an internal
primer and the ABI PRISM Dye Terminator Cycle Sequencing Ready
Reaction kit (Applied Biosystems). The probes were sequenced withExperimental Procedures
the 373A DNA Sequencer (Applied Biosystems). Sequences were
analyzed with the DNASTAR software (DNASTAR Inc.).Mice and Viruses
We obtained 6- to 8-week-old BALB/c mice kept under specific
pathogen–free conditions from Olac, UK. VSV-IND (Mudd–Summers
Southern Blotting Analysis of VH Rearrangementsisolate) was originally obtained from D. Kolakofsky (University of
To analyze VH rearrangements, 10 mg of genomic DNA was digestedGeneva, Switzerland) and were grown on BHK-21 cells (McCaren
with EcoRI and hybridized to the heavy chain enhancer probe (HE-et al., 1959). The VSV-IND variant 51.12 was generated by adhering
probe). The HE-probe was obtained by PCR amplification of BALB/c106 pfu VSV-IND wild type to a monolayer of Vero cells. After overlay-
genomic tail DNA with the upstream primer 136 (59-AGGTCTGGTGGing the infected cells with supernatant of the hybridoma cell line
AGCCTGCAA-39) and the downstream primer 137 (59-TGGGGAAAC51.12, plates were incubated overnight at 378C in an atmosphere
TAGAACTACTCAAGC-39) giving rise to a 640 bp fragment. The 6.4containing 5% CO2. The VSV-IND antibody escape variant 51.12 kb restriction fragment showing up after hybridization was obtainedwas isolated from the supernatant and was plaque purified three
from genomic DNA isolated from the myeloma fusion partnertimes.
X63Ag8.653 as well as from genomicliver DNA of BALB/c mice. Thus
the 6.4kb restriction fragment either derived from the unproductively
Generation of VSV-IND-Specific Hybridomas rearranged VH allele of the myeloma alone or additionally from an
For the generation of monoclonal VSV-IND-specific IgG-secreting unrearranged VH allele of the fused B cell.
hybridomas BALB/c mice were infected intravenously with 2 3 106
pfu VSV-IND, and spleen cells were fused 4 and 5 days after infec-
VSV Neutralization Testtion with the immunoglobulin nonproducing myeloma cell line
Serial 2-fold dilutions of antibody samples were mixed with equalX63Ag8.653 as described previously (Roost et al., 1995). VSV-spe-
volumes of virus containing 500 pfu per milliliter. The mixtures werecific hybridomas were screened with an ELISA assay. In brief, puri-
incubated for 90 min at 378C in an atmosphere containing 5% CO2.fied VSV-IND was coated to plastic plates. After blocking with 3%
Then 100 ml of the mixtures was transferred onto Vero cell mono-bovine serum albumin, supernatant of hybridoma cells was added
layers in 96-well plates and incubated for 1 hr at 378C. The mono-and IgG and IgM antibodies specifically binding to VSV-IND were
layers were overlaid with 100 ml of Dulbecco’s modified Eagle’sdetected with horseradish peroxidase–conjugated anti–mouse IgG
medium containing 1% methylcellulose. After incubation for 24 hrand anti–mouse IgM reagents (Zymed), which were revealed by the
at 378C, the overlay was removed and the monolayer was fixed andABTS substrate. Fusions gave rise to about 20 IgG- and 60 IgM-
stained with 0.5% crystal violet dissolved in 5% formaldehyde, 50%secreting hybridomas per spleen 4 days after infection and equal
ethanol, 4.25% NaCl. The dilution reducing the number of plaquesnumbers of IgG- and IgM-secreting hybridomas 5 days after infec-
by 50% was taken as titer (Charan and Zinkernagel, 1986).tion that specifically bound VSV.
Secondary response IgGs were generated 9 days after intrave-
nous infection of BALB/c mice with VSV-IND and a booster immuni-
Avidity Measurementzation on day 9. Hyperimmune response IgGs were generated on
Avidity was determined directly from the hybridoma supernatantsday 150 after regular boosting at intervals of 3 weeks (Roost et al.,
by an ELISA solid-phase method as described before (Beatty et al.,1995).
1987a, 1987b; Roost et al., 1995). In brief, ELISA plates were coated
with purified VSV at three different densities, and antibody concen-
Analysis of V Gene Diversity by Northern Dot trations leading to half-maximal absorbance were determined. The
Blot Hybridization three values for antibody input concentration needed for half-maxi-
For the analysis of the V gene diversity of secondary and hyperim- mal binding allowed the extrapolation of the avidity independent of
mune response IgGs, RNA extracts were prepared from 107 hybrid- the coated antigen density (Beatty et al., 1987b).
oma cells by NP-40 lysis (White and Bancroft, 1982). The RNA ex-
tracts were applied to nylon filters, and the concentration of
immunoglobulin mRNA in the extracts was standardized by a CK- Binding Competition Analysis
A single cell suspension of 106 VSV-IND-infected EL4 cells express-specific hybridization prior to probing with the V gene family– and
J segment–specific probes. Hybridizations with primers specifically ing VSV-G were incubated for 10 min at 48C with saturating amounts
of VSV-IND-neutralizing mouse antibody. Afterward, a limiting dilu-hybridizing to all JH and JK segments (Duchosal et al., 1989) and
hybridizations with the following V gene family specific probes have tion of rat VSV-IND-neutralizing antibody IND5H6 giving 95% of
maximal staining was added and incubated for another 20 min atbeen performed for this study: VH family–specific probes, VHJ558,
VHQ52, VH36-60, VHX24, VH7183, VHJ606, VHS107, VH3609, VHVGam3-8, 48C. Cells were washed and bound rat antibody was monitored with
a phycoerythrin-labeled goat anti-rat antibody (Southern Biotech-VH10, and VH11 (Kofler, 1988; Reininger et al., 1988; Duchosal et al.,
1989); VK family–specific probes, VK1, VK2, VK5, VK9, VK10, VK12, VK14, nology Associates). Probes were flow cytometrically analyzed in a
FACScan analyzer (Beckton Dickinson).VK21, VK23, VK24, VK19-28, and VKRF (Kofler et al., 1989).
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